RegentAtlantic Capital’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-15,753
| Closed | -$42K | – | 457 |
|
|
2019
Q4 | $42K | Sell |
15,753
-2,492
| -14% | -$6.64K | ﹤0.01% | 460 |
|
|
2019
Q3 | $62K | Buy |
+18,245
| New | +$62K | ﹤0.01% | 439 |
|
|
2019
Q1 | – | Sell |
-3,495
| Closed | -$22K | – | 437 |
|
|
2018
Q4 | $22K | Hold |
3,495
| – | – | ﹤0.01% | 401 |
|
|
2018
Q3 | $57K | Hold |
3,495
| – | – | ﹤0.01% | 430 |
|
|
2018
Q2 | $72K | Hold |
3,495
| – | – | 0.01% | 403 |
|
|
2018
Q1 | $82K | Sell |
3,495
-1,000
| -22% | -$23.5K | 0.01% | 406 |
|
|
2017
Q4 | $842K | Sell |
4,495
-1,125
| -20% | -$211K | 0.07% | 231 |
|
|
2017
Q3 | $1.21M | Sell |
5,620
-1,125
| -17% | -$241K | 0.1% | 192 |
|
|
2017
Q2 | $1.38M | Sell |
6,745
-5
| -0.1% | -$1.03K | 0.13% | 173 |
|
|
2017
Q1 | $1.23M | Buy |
+6,750
| New | +$1.23M | 0.11% | 181 |
|
|
2016
Q4 | – | Sell |
-1,125
| Closed | -$234K | – | 392 |
|
|
2016
Q3 | $234K | Buy |
+1,125
| New | +$234K | 0.02% | 353 |
|